Bearing in mind that disruption of cardiovascular metabolism seems to play a crucial role in CVD after chronic irradiation [10,11,43], a possible approach would be to evaluate the effect of pharmacological activation of PPARα, a key transcription factor of metabolism in the prevention of radiation-associated heart disease [79]. This evidence concerns the gene PPARA and heart disorder.